Fox Run Management’s Precigen PGEN Stock Holding History

Fox Run Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-20,500	Closed	-$390K	–	834
2017 Q3	$390K	Buy	+20,500	New	+$422K	0.11%	386

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fox Run Management's PGEN Position: Q4 2017 in Review

Fox Run Management sold out of Precigen (PGEN) in Q4 2017, closing a stake of 20,500 shares — an estimated $390K sold.

Fox Run Management first reported a position in PGEN in Q3 2017 and held it in 1 quarter. The position peaked at $390K in Q3 2017. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

Fox Run Management reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
Fox Run Management sold 20,500 Precigen shares in Q4 2017, an estimated $390K.
Fox Run Management first reported a position in Precigen in Q3 2017 and held it in 1 quarter.
Fox Run Management's Precigen position peaked at $390K in Q3 2017.
162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on Fox Run Management's 13F filing for Q4 2017, filed 18 Jan 2018.